Cargando…

Usefulness of Probiotics in the Management of NAFLD: Evidence and Involved Mechanisms of Action from Preclinical and Human Models

The present review aims at analyzing the current evidence regarding probiotic administration for non-alcoholic fatty liver disease (NAFLD) management. Additionally, the involved mechanisms of action modulated by probiotic administration, as well as the eventual limitations of this therapeutic approa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arellano-García, Laura, Portillo, María P., Martínez, J. Alfredo, Milton-Laskibar, Iñaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950320/ https://www.ncbi.nlm.nih.gov/pubmed/35328587 http://dx.doi.org/10.3390/ijms23063167

Ejemplares similares

Beneficial Effects of Viable and Heat-Inactivated Lactobacillus rhamnosus GG Administration on Oxidative Stress and Inflammation in Diet-Induced NAFLD in Rats
por: Arellano-García, Laura, et al.
Publicado: (2023)

Current Knowledge on Beetroot Bioactive Compounds: Role of Nitrate and Betalains in Health and Disease
por: Milton-Laskibar, Iñaki, et al.
Publicado: (2021)

An Overview of Adipose Tissue ACE2 Modulation by Diet and Obesity. Potential Implications in COVID-19 Infection and Severity
por: Gómez-Zorita, Saioa, et al.
Publicado: (2021)

Effects of Resveratrol Administration in Liver Injury Prevention as Induced by an Obesogenic Diet: Role of Ruminococcaceae
por: Milton-Laskibar, Iñaki, et al.
Publicado: (2022)

Potential usefulness of Mediterranean diet polyphenols against COVID-19-induced inflammation: a review of the current knowledge
por: Milton-Laskibar, Iñaki, et al.
Publicado: (2022)

Involvement of 5′AMP-Activated Protein Kinase (AMPK) in the Effects of Resveratrol on Liver Steatosis
por: Trepiana, Jenifer, et al.
Publicado: (2018)

Do the Effects of Resveratrol on Thermogenic and Oxidative Capacities in IBAT and Skeletal Muscle Depend on Feeding Conditions?
por: Milton-Laskibar, Iñaki, et al.
Publicado: (2018)

Key Aspects in Nutritional Management of COVID-19 Patients
por: Fernández-Quintela, Alfredo, et al.
Publicado: (2020)

Resveratrol-Induced Effects on Body Fat Differ Depending on Feeding Conditions
por: Milton-Laskibar, Iñaki, et al.
Publicado: (2017)

Relationship between changes in microbiota induced by resveratrol and its anti-diabetic effect on type 2 diabetes
por: Fernandez-Quintela, Alfredo, et al.
Publicado: (2023)

Gut Microbiota Induced by Pterostilbene and Resveratrol in High-Fat-High-Fructose Fed Rats: Putative Role in Steatohepatitis Onset
por: Milton-Laskibar, Iñaki, et al.
Publicado: (2021)

Role of Omentin, Vaspin, Cardiotrophin-1, TWEAK and NOV/CCN3 in Obesity and Diabetes Development
por: Escoté, Xavier, et al.
Publicado: (2017)

Features of Non-Alcoholic Beer on Cardiovascular Biomarkers. Can It Be a Substitute for Conventional Beer?
por: Sancén, Marco, et al.
Publicado: (2022)

Lack of Additive Effects of Resveratrol and Energy Restriction in the Treatment of Hepatic Steatosis in Rats
por: Milton-Laskibar, Iñaki, et al.
Publicado: (2017)

Beneficial Effects of ε-Viniferin on Obesity and Related Health Alterations
por: Gómez-Zorita, Saioa, et al.
Publicado: (2023)

Anti-Obesity Effects of Macroalgae
por: Gómez-Zorita, Saioa, et al.
Publicado: (2020)

Relationship between Changes in Microbiota and Liver Steatosis Induced by High-Fat Feeding—A Review of Rodent Models
por: Gómez-Zorita, Saioa, et al.
Publicado: (2019)

Anti-Obesity Effects of Microalgae
por: Gómez-Zorita, Saioa, et al.
Publicado: (2019)

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD
por: Perumpail, Brandon J., et al.
Publicado: (2019)

Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma
por: Smiriglia, Alfredo, et al.
Publicado: (2023)

The Role of Choline, Soy Isoflavones, and Probiotics as Adjuvant Treatments in the Prevention and Management of NAFLD in Postmenopausal Women
por: DiStefano, Johanna K.
Publicado: (2023)

NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models
por: Fang, Jing, et al.
Publicado: (2023)

Mechanisms of Action of Probiotics in Intestinal Diseases
por: O'Hara, Ann M., et al.
Publicado: (2006)

Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention
por: Campagnoli, Lucrezia Irene Maria, et al.
Publicado: (2022)

Hunger & satiety signals: another key mechanism involved in the NAFLD pathway
por: López-Méndez, Iván, et al.
Publicado: (2023)

NAFLD/MAFLD: New Evidence
por: Mantovani, Alessandro, et al.
Publicado: (2023)

Mechanism of Action of Streptococcus downii, a New Bacterial Species with Probiotic Potential
por: Martínez-Lamas, Lucía, et al.
Publicado: (2023)

Cyclophosphamide mechanism of action in preclinical tecemotide studies
por: Hance, Ken, et al.
Publicado: (2013)

Current Management of NAFLD
por: MUNTEANU, MIHAI ALEXANDRU, et al.
Publicado: (2016)

Resveratrol: Anti-Obesity Mechanisms of Action
por: Aguirre, Leixuri, et al.
Publicado: (2014)

Preclinical evidence of probiotics in ulcerative colitis: a systematic review and network meta-analysis
por: Jin, Wenqin, et al.
Publicado: (2023)

Probiotic Therapy With VSL#3(®) in Patients With NAFLD: A Randomized Clinical Trial
por: Derosa, Giuseppe, et al.
Publicado: (2022)

NAFLD Preclinical Models: More than a Handful, Less of a Concern?
por: Oligschlaeger, Yvonne, et al.
Publicado: (2020)

Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm
por: Chua, Damien, et al.
Publicado: (2022)

The Common Mechanisms of Sarcopenia and NAFLD
por: Zhai, Yu, et al.
Publicado: (2017)

NAFLD: Mechanisms, Treatments, and Biomarkers
por: Nassir, Fatiha
Publicado: (2022)

Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD
por: Jiang, Xiaofan, et al.
Publicado: (2020)

Plants Used in Mexican Traditional Medicine for the Management of Urolithiasis: A Review of Preclinical Evidence, Bioactive Compounds, and Molecular Mechanisms
por: Sansores-España, Delia, et al.
Publicado: (2022)

The Role of Metformin in the Management of NAFLD
por: Mazza, Angela, et al.
Publicado: (2012)

Effect of Wakame and Carob Pod Snacks on Non-Alcoholic Fatty Liver Disease
por: Rico, Daniel, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lba6686i1iloace7a5mu087lm9